Amend Surgical Receives Funding for Suture-less Nerve Repair Device

UF Innovate | Accelerate client Amend Surgical, Inc.,  an Alachua-based medical device company has been awarded substantial product development funding from The Michigan-Pittsburgh-Wyss Regenerative Medicine (MPWRM) Resource Center to commercialize a novel, suture-less solution for the repair of peripheral nerves. Tissure is a resorbable hydrogel membrane with a chitosan-based adhesive that has the adhesion and mechanical strength to potentially replace sutures for the repair of peripheral nerve injuries. Tissure is easy to apply and will greatly simplify this challenging surgical procedure. Amend Surgical exclusively licensed the rights for this technology from the Wyss Institute at Harvard University in 2020.

“We are committed to providing clinicians innovative and effective options for the treatment of oral tissue wounds including the repair of peripheral nerves. Our initial commercialization efforts will be focused on oral surgery, but we anticipate that Tissure will fill a significant unmet need in the entire peripheral nerve market,” said Robby Lane, Chief Executive Officer of Amend Surgical.

Read more about Amend Surgical Receives Funding for Suture-less Nerve Repair Device.